Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Long

Showing results (1021-1030 of 1,328) with videos related to

Pageof 133
Sort By:
Nature Communications|December 5, 2024
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancerSpencer R Rosario, Mark D Long, Shanmuga Chilakapati, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2009
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myelomaCristina Gasparetto, Jon P Gockerman, Louis F Diehl, et al.
Bone Marrow Transplantation|July 7, 2020
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantationKo K Maung, Benny J Chen, Ian Barak, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor AntagonistDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Frontiers in Aging Neuroscience|May 6, 2014
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD StudyJane S Paulsen, Jeffrey D Long, Hans J Johnson, et al.
Blood Cancer Journal|May 22, 2023
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myelomaLinda B Baughn, Erik Jessen, Neeraj Sharma, et al.
Brain Connectivity|October 19, 2012
Multicenter reliability of diffusion tensor imagingVincent A Magnotta, Joy T Matsui, Dawei Liu, et al.
Bone Marrow Transplantation|January 22, 2013
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentJ Kanda, L Kaynar, Y Kanda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipationDaniel D Long, Scott R Armstrong, David T Beattie, et al.
American Journal of Human Genetics|June 27, 2020
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsKyung-Hee Kim, Eun Pyo Hong, Jun Wan Shin, et al.
Pageof 133

Showing results (1021-1030 of 1,328) with videos related to

Sort By:
Pageof 133
Nature Communications|December 5, 2024
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancerSpencer R Rosario, Mark D Long, Shanmuga Chilakapati, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2009
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myelomaCristina Gasparetto, Jon P Gockerman, Louis F Diehl, et al.
Bone Marrow Transplantation|July 7, 2020
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantationKo K Maung, Benny J Chen, Ian Barak, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Axelopran (TD-1211): A Peripherally Restricted μ-Opioid Receptor AntagonistDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Frontiers in Aging Neuroscience|May 6, 2014
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD StudyJane S Paulsen, Jeffrey D Long, Hans J Johnson, et al.
Blood Cancer Journal|May 22, 2023
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myelomaLinda B Baughn, Erik Jessen, Neeraj Sharma, et al.
Brain Connectivity|October 19, 2012
Multicenter reliability of diffusion tensor imagingVincent A Magnotta, Joy T Matsui, Dawei Liu, et al.
Bone Marrow Transplantation|January 22, 2013
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentJ Kanda, L Kaynar, Y Kanda, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipationDaniel D Long, Scott R Armstrong, David T Beattie, et al.
American Journal of Human Genetics|June 27, 2020
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsKyung-Hee Kim, Eun Pyo Hong, Jun Wan Shin, et al.
Pageof 133